VALENTE, SERAFINA
 Distribuzione geografica
Continente #
NA - Nord America 10.292
EU - Europa 8.503
AS - Asia 4.759
SA - Sud America 1.276
AF - Africa 129
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 24.972
Nazione #
US - Stati Uniti d'America 10.121
IT - Italia 2.699
RU - Federazione Russa 2.405
SG - Singapore 1.716
CN - Cina 1.251
BR - Brasile 1.090
IE - Irlanda 832
GB - Regno Unito 692
DE - Germania 491
HK - Hong Kong 445
VN - Vietnam 390
KR - Corea 376
FI - Finlandia 306
SE - Svezia 298
FR - Francia 244
IN - India 190
NL - Olanda 156
CA - Canada 84
ES - Italia 73
AR - Argentina 64
MX - Messico 63
PL - Polonia 59
AT - Austria 52
BD - Bangladesh 51
JP - Giappone 47
UA - Ucraina 44
EC - Ecuador 41
ZA - Sudafrica 37
ID - Indonesia 36
CI - Costa d'Avorio 35
CZ - Repubblica Ceca 35
IR - Iran 35
IQ - Iraq 31
TR - Turchia 31
UZ - Uzbekistan 24
CH - Svizzera 17
LT - Lituania 17
PK - Pakistan 17
CL - Cile 16
CO - Colombia 16
PE - Perù 16
PH - Filippine 16
MA - Marocco 14
PY - Paraguay 14
BE - Belgio 13
AE - Emirati Arabi Uniti 12
SA - Arabia Saudita 12
VE - Venezuela 12
AL - Albania 11
EG - Egitto 11
BG - Bulgaria 8
DK - Danimarca 8
DZ - Algeria 8
JO - Giordania 8
DO - Repubblica Dominicana 7
KE - Kenya 7
AZ - Azerbaigian 6
KZ - Kazakistan 6
LV - Lettonia 6
TN - Tunisia 6
UY - Uruguay 6
CY - Cipro 5
EE - Estonia 5
EU - Europa 5
IL - Israele 5
MY - Malesia 5
NP - Nepal 5
QA - Qatar 5
AU - Australia 4
HU - Ungheria 4
MK - Macedonia 4
TH - Thailandia 4
TW - Taiwan 4
BB - Barbados 3
BY - Bielorussia 3
ET - Etiopia 3
GE - Georgia 3
JM - Giamaica 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
BH - Bahrain 2
CR - Costa Rica 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
LU - Lussemburgo 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
Totale 24.950
Città #
Dallas 6.180
Singapore 1.142
Dublin 795
Moscow 757
Southend 508
Ashburn 492
Hefei 460
Santa Clara 443
Hong Kong 441
Milan 407
Seoul 375
Chandler 310
Siena 307
Munich 278
Beijing 266
Helsinki 190
Los Angeles 184
Florence 183
Fairfield 178
Rome 174
New York 154
Ho Chi Minh City 136
São Paulo 112
Princeton 95
Houston 90
Bengaluru 84
Buffalo 81
Seattle 79
Nuremberg 74
Hanoi 69
Woodbridge 69
Shanghai 63
Cambridge 62
Chicago 60
Ann Arbor 59
Redondo Beach 57
Turku 57
Wilmington 57
Lappeenranta 46
Rio de Janeiro 45
The Dalles 45
Warsaw 45
Bologna 44
Dong Ket 43
Lauterbourg 42
Tokyo 42
London 40
Guangzhou 36
Naples 36
Abidjan 35
Brescia 35
Málaga 35
Denver 33
Brooklyn 29
Fremont 28
Montreal 28
Poplar 28
San Diego 26
Boardman 25
Council Bluffs 25
Portsmouth 25
Johannesburg 24
Mexico City 24
Stockholm 24
Turin 23
Düsseldorf 22
San Mateo 22
Toronto 22
Mumbai 21
Vienna 21
Atlanta 20
Frankfurt am Main 20
Orem 20
Tashkent 20
Boston 19
Washington 19
Brno 18
Padova 18
Phoenix 18
Piscataway 18
Salt Lake City 18
Salvador 18
Brasília 17
Chennai 17
Guayaquil 16
Porto Alegre 16
Baghdad 15
Curitiba 15
Guarulhos 15
Haiphong 15
Manchester 15
Amsterdam 14
Belo Horizonte 14
Biên Hòa 14
Lima 14
Modena 14
Newark 14
Palermo 14
Ankara 13
Charlotte 13
Totale 17.038
Nome #
Vo2peak, Ve/VCO2, and Cardiac Remodeling Correlate with Long-Term Cardiovascular Outcome in Heart Failure Patients 1.230
Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect in Athletes: A Study With a Long-Term Follow-Up 746
Antiplatelet and Anticoagulation Therapy in Athletes: A Cautious Compromise… If Possible! 606
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 545
A first update on mapping the human genetic architecture of COVID-19 539
Il test da sforzo cardiopolmonare: uno strumento fondamentale per una prescrizione personalizzata dell’esercizio fisico nei pazienti con malattia cardiovascolare : Cardiopulmonary exercise testing: an essential tool for a tailored exercise prescription in patients with cardiac disease 469
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 459
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 455
Prognostic value of left atrial strain in acute and chronic heart failure: A meta-analysis 417
Left Ventricular Mass with Delayed Enhancement as a Predictor of Major Events in Patients with Myocarditis with Preserved Ejection Fraction 414
Pressure-strain loops unveil haemodynamics behind mechanical circulatory support systems 386
The loss of left atrial contractile function predicts a worse outcome in HFrEF patients 338
Genetic mechanisms of critical illness in COVID-19 332
Antirheumatic agents in covid-19: is IL-6 the right target? 330
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 328
An explainable model of host genetic interactions linked to COVID-19 severity 325
The role of cardiac computed tomography in sports cardiology: back to the future! 319
Peripheral biomarkers' panel for severe COVID-19 patients 291
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 286
Pathogen-sugar interactions revealed by universal saturation transfer analysis 270
Mapping the human genetic architecture of COVID-19 263
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 245
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 232
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 226
Prognostic bioindicators in severe COVID-19 patients 217
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 216
Left atrial strain by speckle tracking predicts atrial fibrosis in patients undergoing heart transplantation 215
Serial KL-6 measurements in COVID-19 patients 212
A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play 210
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 205
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 201
The importance of ventilatory thresholds to define aerobic exercise intensity in cardiac patients and healthy subjects 198
Ablation therapy for ventricular arrhythmias in patients with LVAD: Multiple faces of an electrophysiological challenge 198
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 197
Clinician approach to cardiopulmonary exercise testing for exercise prescription in patients at risk of and with cardiovascular disease 195
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 191
Right ventricular dysfunction in left ventricular assist device candidates: is it time to change our prospective? 189
SARS-CoV-2 in pleural fluid in a kidney transplant patient 189
A multidisciplinary approach for the emergency care of patients with left ventricular assist devices: A practical guide 188
Causes of sudden cardiac death in young athletes and non-athletes: systematic review and meta-analysis: Sudden cardiac death in the young 185
Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients 183
Detection of cardiac allograft vasculopathy by multi-layer left ventricular longitudinal strain in heart transplant recipients 182
Clinical, echocardiographic and hemodynamic predictors of right heart failure after LVAD placement 181
Basic and advanced echocardiography in advanced heart failure: an overview 177
ACUTE HF score: a new multi-parametric score for the prognostication of acute heart failure 175
Bedside Ultrasound for Hemodynamic Monitoring in Cardiac Intensive Care Unit 175
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol 175
Survival in acute heart failure in intensive cardiac care unit: a prospective study 172
Impact of SARS-CoV-2 outbreak on heart and lung transplant: a patient-perspective survey 169
Clinical management of young competitive athletes with premature ventricular beats: A prospective cohort study 169
Cardiogenic shock and acute kidney injury: the rule rather than the exception 168
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 167
Clinical and molecular characterization of COVID-19 hospitalized patients 166
Aortic root/left ventricular diameters golden ratio in competitive athletes 165
Left atrial strain as a pre-operative prognostic marker for patients with severe mitral regurgitation 165
ADONHERS (Aged DONor HEart Rescue by Stress Echo) National Protocol: Recipient's Survival after 10-Year Follow-Up 164
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 158
Right ventricular myocardial work for the prediction of early right heart failure and long-term mortality after left ventricular assist device implant 154
High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab 154
Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women 153
How to evaluate resting ECG and imaging in children practising sport: a critical review and proposal of an algorithm for ECG interpretation 148
SARS-CoV-2 infection and return to play in junior competitive athletes: is systematic cardiac screening needed? 147
Left ventricular fibrosis as a main determinant of filling pressures and left atrial function in advanced heart failure 145
Correlation of Left Ventricular Myocardial Work Indices with Invasive Measurement of Stroke Work in Patients with Advanced Heart Failure 145
Diastolic function in heart transplant: From physiology to echocardiographic assessment and prognosis 145
Whole-genome sequencing reveals host factors underlying critical COVID-19 143
Echocardiography for left ventricular assist device implantation and evaluation: an indispensable tool 141
Cardiopulmonary Fitness and Personalized Exercise Prescription in Patients With Hypertrophic Cardiomyopathy 137
Safe performance of echocardiography during the COVID-19 pandemic: A practical guide 135
Left ventricular assist device in cardiac amyloidosis: friend or foe? 133
Risk stratification in cardiogenic shock: a focus on the available evidence 133
COVID-19 and the burning issue of drug interaction: Never forget the ECG 132
Heart transplantation and anti-HLA antibodY: myocardial dysfunction and prognosis - HeartLAy study 131
Usefulness of echocardiography to detect cardiac involvement in COVID-19 patients 129
The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences 129
Left ventricular assist device and transcatheter edge-to-edge mitral valve repair in advanced heart failure: allies or enemies? 128
Prediction of congestive state in acute and chronic heart failure: The association between NT-proBNP and left atrial strain and its prognostic value 126
Two and Three-Dimensional Echocardiography in Primary Mitral Regurgitation: Practical Hints to Optimize the Surgical Planning 126
COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications 125
Post-acute sequelae of COVID-19: the potential role of exercise therapy in treating patients and athletes returning to play 124
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience 124
Zero-fluoroscopy catheter ablation of premature ventricular contractions at left coronary cusp near left main coronary artery 122
Dapagliflozin Effects on Cardiac Deformation in Heart Failure and Secondary Clinical Outcome 120
Hemodynamic variations and pitfalls during venoarterial extracorporeal membrane oxygenation and left ventricular apical unloading as bridge to heart transplantation 120
Case Report: Two Case Reports of Acute Myopericarditis After mRNA COVID-19 Vaccine 118
Tricuspid Regurgitation Velocity and Mean Pressure Gradient for the Prediction of Pulmonary Hypertension According to the New Hemodynamic Definition 116
Insight into Atrial Fibrillation in LVAD Patients: From Clinical Implications to Prognosis 112
Acute coronary syndromes during COVID-19 111
ANMCO Position Paper: Amyloidosis for the clinical cardiologist. A "clinical primer" from the ANMCO Rare Disease Working Group [Position paper ANMCO: L’amiloidosi per il cardiologo clinico. Un “clinical primer” dell’Area Malattie Rare ANMCO] 110
ANMCO Position Paper: Appropriateness of prescribing direct oral anticoagulants in stroke and systemic thromboembolism prevention in adult patients with non-valvular atrial fibrillation 110
From Coronary Artery Ectasia to Giant Coronary Artery Aneurysm: Is it Necessary to Follow-Up? 108
Maternal Anti-Ro/SSA Autoantibodies and Prolonged PR Interval in a Competitive Athlete: Beyond Training-Induced Electrical Remodeling 108
COVID-19 in patients with heart failure: the new and the old epidemic 108
ANMCO Position Paper: Cardiovascular disease in women - Prevention, diagnosis, treatment and organization of care ANMCO Position Paper: Cardiovascular disease in women - Prevention, diagnosis, treatment and organization of care 103
The acute effects of an ultramarathon on atrial function and supraventricular arrhythmias in master athletes 102
ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes 100
Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence 100
Myocardial Work Indices Predict Hospitalization in Patients with Advanced Heart Failure 99
ANMCO Position paper: Care pathway for advanced heart failure patients candidate for heart transplantation/ventricular assist device [Position paper ANMCO: Percorso assistenziale del paziente con insufficienza cardiaca avanzata candidabile a trapianto/assistenza ventricolare meccanica] 99
Adherence of ticagrelOr in real world patients with aCute coronary syndrome: The AD-HOC study 98
Totale 21.519
Categoria #
all - tutte 74.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021669 0 0 0 0 0 59 101 108 137 58 113 93
2021/20221.223 102 96 72 68 64 81 122 80 57 103 144 234
2022/20231.517 88 139 178 136 98 220 130 137 92 83 88 128
2023/20242.045 93 88 204 172 104 363 561 96 40 79 67 178
2024/20255.896 167 188 468 265 499 687 531 366 516 312 543 1.354
2025/202614.007 924 4.187 3.860 2.069 2.799 168 0 0 0 0 0 0
Totale 25.715